These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7826595)

  • 21. Primary sclerosing cholangitis.
    Stiehl A; Benz C; Sauer P
    Can J Gastroenterol; 2000 Apr; 14(4):311-5. PubMed ID: 10799084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paradoxical progression of biliary strictures against recovery of biochemical parameters under ursodeoxycholic acid treatment in a case of primary sclerosing cholangitis with ulcerative colitis.
    Komatsu K; Shimosegawa T; Kikuchi S; Uchi M; Maruhama Y; Kisara N; Ueno Y; Toyota T
    Intern Med; 2000 Dec; 39(12):1049-53. PubMed ID: 11197788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A clinical and pathological analysis of 22 cases of primary sclerosing cholangitis].
    Liu HH; Fu JL; Luo SQ; Sun YL; Dong JH; Guo TS; Wang FS
    Zhonghua Gan Zang Bing Za Zhi; 2013 Feb; 21(2):125-8. PubMed ID: 23663885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Primary sclerosing cholangitis].
    Stiehl A
    Internist (Berl); 2004 Jan; 45(1):27-32. PubMed ID: 14735241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary sclerosing cholangitis: summary of a workshop.
    LaRusso NF; Shneider BL; Black D; Gores GJ; James SP; Doo E; Hoofnagle JH
    Hepatology; 2006 Sep; 44(3):746-64. PubMed ID: 16941705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Primary sclerosing cholangitis].
    Rasmussen HH; Fallingborg JF; Mortensen PB; Freund LG; Tage-Jensen U; Rasmussen SN
    Ugeskr Laeger; 1991 May; 153(21):1487-91. PubMed ID: 2053198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary sclerosing cholangitis in a child.
    Lin WT; Lin SJ; Ni YH; Chen HL; Wang HP; Chu JS; Chang MH
    J Formos Med Assoc; 1999 Mar; 98(3):209-13. PubMed ID: 10365542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics and long-term prognosis of the autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome.
    Lüth S; Kanzler S; Frenzel C; Kasper HU; Dienes HP; Schramm C; Galle PR; Herkel J; Lohse AW
    J Clin Gastroenterol; 2009 Jan; 43(1):75-80. PubMed ID: 18769363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis of primary sclerosing cholangitis.
    Harrison PM
    J Hepatobiliary Pancreat Surg; 1999; 6(4):356-60. PubMed ID: 10664281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of cholestatic disease in 2017.
    de Vries E; Beuers U
    Liver Int; 2017 Jan; 37 Suppl 1():123-129. PubMed ID: 28052628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of Ursodeoxycholic Acid in the Treatment of Primary Sclerosing Cholangitis with Ulcerative Colitis: A Pediatric Case.
    Fujita Y; Sugaya T; Inui A; Yoshihara S
    Tohoku J Exp Med; 2021 Feb; 253(2):109-112. PubMed ID: 33551380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD.
    Sabino J; Vieira-Silva S; Machiels K; Joossens M; Falony G; Ballet V; Ferrante M; Van Assche G; Van der Merwe S; Vermeire S; Raes J
    Gut; 2016 Oct; 65(10):1681-9. PubMed ID: 27207975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary sclerosing cholangitis.
    Geonzon-Gonzales MR
    Gastroenterol Nurs; 2007; 30(2):102-5; quiz 105-7. PubMed ID: 17440311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary sclerosing cholangitis in pregnancy refractory to ursodeoxycholic acid treatment: a case report.
    Leftwich H; Fang YM; Borgida A; Crombleholme W
    J Reprod Med; 2010; 55(11-12):517-9. PubMed ID: 21291041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective, randomized-controlled pilot study of ursodeoxycholic acid combined with mycophenolate mofetil in the treatment of primary sclerosing cholangitis.
    Sterling RK; Salvatori JJ; Luketic VA; Sanyal AJ; Fulcher AS; Stravitz RT; Contos MJ; Mills AS; Shiffman ML
    Aliment Pharmacol Ther; 2004 Nov; 20(9):943-9. PubMed ID: 15521841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Primary sclerosing cholangitis and inflammatory bowel disease].
    Schrumpf E; Fausa O; Aadland E; Elgjo K; Kolmannskog F
    Tidsskr Nor Laegeforen; 1990 Apr; 110(10):1212-6. PubMed ID: 1970674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does ursodeoxycholic acid mediate immunomodulatory and anti-inflammatory effects in patients with primary sclerosing cholangitis?
    van Milligen de Wit AW; Kuiper H; Camoglio L; van Bracht J; Jones EA; Tytgat GN; van Deventer SJ
    Eur J Gastroenterol Hepatol; 1999 Feb; 11(2):129-36. PubMed ID: 10102223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A retrospective single-center review of primary sclerosing cholangitis in children.
    Miloh T; Arnon R; Shneider B; Suchy F; Kerkar N
    Clin Gastroenterol Hepatol; 2009 Feb; 7(2):239-45. PubMed ID: 19121649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medical treatment of primary sclerosing cholangitis.
    Lee YM; Kaplan MM
    J Hepatobiliary Pancreat Surg; 1999; 6(4):361-5. PubMed ID: 10664282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial.
    Beuers U; Spengler U; Kruis W; Aydemir U; Wiebecke B; Heldwein W; Weinzierl M; Pape GR; Sauerbruch T; Paumgartner G
    Hepatology; 1992 Sep; 16(3):707-14. PubMed ID: 1505913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.